Home›Search›Nano TransMed

Nano TransMed

KeAi Publishing Communications Ltd. · China · Est. 2022

ISSN2790-6760

SJR Q1✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total40

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Score

0.962

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Works

106

Total Citations

1,743

2yr Mean Citedness

17.10

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

This journal focuses on the application of nanotechnology and nanomedicine for therapeutic and diagnostic purposes. It covers the development and evaluation of nanoformulations for drug delivery, targeting, and overcoming challenges such as poor solubility, bioavailability, and drug resistance in various diseases including cancer, hypertension, diabetes, and malaria. The journal also explores the use of nanomaterials in tissue engineering, biosensing, and antimicrobial strategies, as well as computational approaches for nano-drug design.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Fast · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionChina

Primary LanguageEnglish

1st Year Published2022

FrequencyAnnual, 2024-

StatusActive (last: 2026)

Total Publications106

Publisher OrgElsevier BV

OA Since2021

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~8 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

Koninklijke BibliotheekPorticoCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

KeAi Publishing Communications Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2790-6760

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Koninklijke Bibliotheek, Portico, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q1

Pharmacology (medical)Q2

Subject Classification

Scopus Categories

Pharmacology (medical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsNanoparticles: synthesis and applicationsGraphene and Nanomaterials ApplicationsExtracellular vesicles in diseaseRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesAdvanced Nanomaterials in CatalysisCurcumin's Biomedical ApplicationsBone Tissue Engineering Materials